We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Trial of a Social Networks Intervention (AVID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03059433
Recruitment Status : Completed
First Posted : February 23, 2017
Last Update Posted : October 3, 2022
Sponsor:
Collaborator:
Robert Wood Johnson Foundation
Information provided by (Responsible Party):
Rebecca Dudovitz, MD, MSHS, University of California, Los Angeles

Brief Summary:

Advancement via Individual Determination (AVID) is a college preparatory program that provides a unique opportunity to determine whether schools can reduce substance use by re-grouping at-risk students with high-performing students, while providing additional academic and emotional support. Operating in 4,837 K-12th grade schools worldwide and across 45 US states, this widely-disseminated program targets students from groups traditionally underrepresented in higher education who are currently performing in the academic middle (i.e., a 2.0-3.5 grade point average). AVID removes these students from typical classrooms and exposes them to a peer network in which academic performance and positive social norms are valued. In addition, by strengthening the student/teacher relationship, AVID expands students' networks of supportive adults. For low-income minority students in the academic middle, relatively small investments in prevention might significantly impact their academic and health trajectories. AVID capitalizes on a moment when social networks are in flux-the transition to high school-to shift these students' trajectories.

This study is a longitudinal, randomized pilot evaluation of AVID among low-income minority adolescents entering high school, comparing academic performance and drug use, as well as other risky behaviors, over 3 years. Although social networks are hypothesized to have a strong influence on behavior, few studies have tried to re-wire networks to change behaviors. This study will provide a clearer understanding of whether schools can intentionally shape networks and whether these changes can reduce substance use. This study will also explore important mechanistic questions about whether and how AVID changes peer networks and relationships with teachers, whether those changes lead to improvements in academic and behavioral outcomes and, if so, what the relative importance of peer versus adult network changes are.


Condition or disease Intervention/treatment
Adolescent Behavior Other: AVID Intervention

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 446 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Leveraging School Environments to Shape Social Networks and Reduce Adolescent Substance Use-A Pilot Randomized Trial of a Social Networks Intervention
Actual Study Start Date : April 21, 2017
Actual Primary Completion Date : July 2, 2021
Actual Study Completion Date : July 6, 2022

Group/Cohort Intervention/treatment
AVID Intervention
175 students will be randomized via lottery by the participating high school to be part of the AVID program. These students will receive 4 surveys (8th, 9th, 10th, and 11th grade).
Other: AVID Intervention
Advancement via Individual Determination (AVID) is a college preparatory program that participating high schools have available to students.
Other Name: AVID

Non AVID
175 students will be randomized via lottery by the participating high school to be part of our control group. This group of students will be similar to the AVID group, except they will not be in the AVID program. They will also complete 4 surveys (8th, 9th, 10th, and 11th grade).
High Performing
175 students who are identified as high performing (middle school grade point average >3.5) by the participating high school. They will also complete 4 surveys (8th, 9th, 10th, and 11th grade).



Primary Outcome Measures :
  1. Change in health of social network [ Time Frame: change in health of social network between baseline and 3 year follow up ]
    Investigators will evaluate whether students randomized to AVID report healthier social networks (lower proportion of peers engaging in risky behaviors and a higher number of supportive adults) than control students.


Secondary Outcome Measures :
  1. Frequency of risky health behaviors [ Time Frame: change in frequency of risky health behaviors between baseline and 3 year follow up ]
    Investigators will determine whether AVID students report decreased frequency of risky health behaviors, such as substance use, violence, and delinquency, compared to control students and whether associations between AVID and risky health behaviors are modified by gender.

  2. Change in peer or adult social network [ Time Frame: change in risky behavior between baseline and 3 year follow up ]
    Investigators will examine whether peer or adult social network changes predict changes in risky health behaviors and, if exposure to AVID is associated with health behaviors, whether these associations are mediated by changes in peer or adult networks.

  3. Assumptions of AVID students' level of their own risky health behaviors [ Time Frame: change in student assumption of risky behavior between baseline and 3 year follow up ]
    Investigators will test whether AVID students assume similar levels of risky health behaviors as reported by high-performing, non-AVID peers, and whether, for high-performing non-AVID peers, a greater proportion of AVID peers in their social network is associated with increased frequency of risky health behaviors.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   13 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Participants must be eighth grade students who are entering a Los Angeles Unified School District high school that is having a lottery for admission into their AVID program.
Criteria

Inclusion Criteria:

  • applied to and was deemed eligible for AVID by the AVID coordinator
  • Student participated in the AVID lottery
  • Parent consents to participate in study
  • Student assents to participate in study

OR

  • Middle school Grade Point Average (GPA) >3.5
  • Planning to attend study high school
  • Parent consents to participate in study
  • Student assents to participate in study

Exclusion Criteria:

  • Student did not apply to AVID
  • Student was deemed ineligible for AVID by the AVID coordinator/local AVID admissions process
  • Student did not participate in the AVID lottery
  • Parent does not consent for study participation
  • Student does not assent for study participation

OR

  • Middle school Grade Point Average (GPA)<3.5
  • Not planning to attend study high school
  • Parent does not consent for study participation
  • Student does not assent for study participation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03059433


Locations
Layout table for location information
United States, California
University of California, Los Angeles (UCLA)
Los Angeles, California, United States, 90095
Sponsors and Collaborators
University of California, Los Angeles
Robert Wood Johnson Foundation
Investigators
Layout table for investigator information
Principal Investigator: Rebecca Dudovitz, MD, MS University of California, Los Angeles
Layout table for additonal information
Responsible Party: Rebecca Dudovitz, MD, MSHS, Principal Investigator, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT03059433    
Other Study ID Numbers: IRB#15-001190
First Posted: February 23, 2017    Key Record Dates
Last Update Posted: October 3, 2022
Last Verified: September 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description:

Participants will be assigned a study ID number to link their name, address, and phone number to their survey responses. This ID will be used for all data collection.

The computer file linking the personal identifiers and the study ID number will be kept separate from the survey data. Personally identifying information pertaining to individual participants will not be shared or made available to other researchers. Any data request will be made to the Principal Investigator and any data shared will be encrypted and will not include any personal identifying information.


Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Rebecca Dudovitz, MD, MSHS, University of California, Los Angeles:
Substance use
adolescent
health
social network